Alnylam Pharmaceuticals, Inc Earning Date (ALNY)

USA |NASDAQ |USD

ALNY Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 9, 2022 Dec 2021 $-1.59 $-1.72 $-2.09
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 9, 2022 Dec 2021 $226.41M $187.63M $163.56M

Alnylam Pharmaceuticals, Inc's next earnings date is Wednesday, Feb 9, 2022 for the fiscal quarter ending Dec 2021.

ALNY Earnings Date & History Chart

ALNY Earnings & Revenue Forecast

ALNY Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 4 $-1.46 $-1.68 $-1.34
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 17 $-3.92 $-6.29 $-1.98

ALNY Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 4 / 2 $-1.49 $-1.47 $-1.47
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 10 / 0 $-4.10 $-3.73 $-3.60

ALNY Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 5 $245.91M $220.00M $269.05M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 19 $1.26B $1.05B $1.48B

ALNY Earnings Date & Revenue History

ALNY Earnings History

|
Show More
Show More

ALNY Revenue History

|
Show More
Show More

Alnylam Pharmaceuticals, Inc Next Earnings Date & Report

ALNY Next Earnings Date & Report Preview: Dec 2021 (FQ)

ALNY's next earnings date is Wednesday, Feb 9, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 17 analysts, the average EPS estimation for Alnylam Pharmaceuticals, Inc's next quarterly earnings is $-1.59, with a low EPS estimation of $-1.97, and a high estimation of $-1.11.

Over the last 1 month, EPS estimates have seen 9 upward revisions and 0 downward. The EPS 1 month trend is $-1.59, the last 2 month trend is $-1.59, and the 3 month trend is $-1.56.

Based on 17 analysts, the average revenue estimation is $226.41M, with a low revenue estimation of $208.00M, and a high estimation of $244.53M.

Alnylam Pharmaceuticals, Inc Previous Earnings Dates & Reports

ALNY Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Alnylam Pharmaceuticals, Inc's previous earnings date was Oct 28, 2021 for its fiscal quarter ended Sep 30, 2021.

ALNY's earnings per share (EPS) was $-1.72, missing the consensus analysts forecast of $-1.57 by -9.71%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 6.83%, and higher than the same period a year before (Sep 2020) by -21.10%.

Revenues were $187.63M, worse than the forecast of $218.69M by -14.20%, down by -14.93% from the previous quarter , and up by 49.09% from the same period last year.

The company reported a net income of $-204.51M.

Free cash flow for the quarter was $-160.10M , compared to $-133.10M last quarter and $-122.74M a year before.

ALNY ended the quarter with $760.44M in total debt, a decrease of -0.08% compared to the previous quarter, and a decrease of -25.07% compared to the same quarter a year before.

ALNY Previous Earnings Date & Report Recap: Dec 2020 (FY)

Alnylam Pharmaceuticals, Inc's previous annual earnings date was Feb 11, 2021 for its fiscal year ended Dec 31, 2020.

ALNY's earnings per share (EPS) was $-7.45, missing the consensus analysts forecast of $-7.18 by 3.76% , and higher than the previous year's EPS (Dec 2019) by -8.48%.

Revenues were $492.85M, better than the forecast of $476.72M by 3.38%, and up by 124.28% from previous year's revenue.

The company reported a net income of $-858.28M.

Alnylam Pharmaceuticals, Inc reported a free cash flow of $-685.32M for its fiscal year, compared to $-418.58M a year ago.

The company ended the fiscal year with $521.19M in total debt, an increase of 71.54% compared to the previous year.